Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy

NAUnknownINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2014

Conditions
Breast Cancer
Interventions
DRUG

Cyclophosphamide and Methotrexate and Aspirin

Cyclophosphamide 50 mg PO daily x 28 days, cycles 1-4 Methotrexate 2.5 mg PO twice daily, days 1 and 2 each week x 4 weeks, cycles 1-4 ASA: 325 mg PO daily x 28 days, cycles 3 and 4 Treatment will be given for a total of 4 cycles.

Trial Locations (3)

11220

RECRUITING

Maimonides Cancer Center, Brooklyn

03756

NOT_YET_RECRUITING

Dartmouth Hitchcock Medical Center, Lebanon

05401

RECRUITING

University of Vermont, Burlington

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Maimonides Medical Center

OTHER

collaborator

Dartmouth-Hitchcock Medical Center

OTHER

lead

University of Vermont

OTHER

NCT01612247 - Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy | Biotech Hunter | Biotech Hunter